• 

  ‘The Problem of Alzheimer’s’ Makes Us Mad—In a Good Way
• 

  As Our Oceans Change, Drugmakers Dive Deep for an Alzheimer’s Cure
• 

  How Young and Old Can Help Each Other Heal & Other March Reads
• 

  CBD for Alzheimer’s? The Cannabidiol Craze Makes Its Way Into Research
• 

  Study: Recovering From Loneliness Even Better for the Brain Than Never Being Lonely
• 

  Managing Language Impairment in Dementia: A LiveTalk With Vicky Fukuhara
• 

  Is Alzheimer’s Actually Three Separate Diseases?
• 

  Does Eli Lilly’s Alzheimer’s Drug Donanemab Work? Key New Data Released
• 

  Expert Q&A: Financial and Insurance Planning After a Dementia Diagnosis
• 

  Researchers Explore a New Therapy to Address the Neurological Symptoms of COVID
• 

  Now Recruiting: U.S. Trials for Alzheimer’s “Seaweed Drug” Oligomannate
• 

  Getting To The Point: Considering Acupuncture for Cognitive Decline
• 

  What Biden Should Do for Alzheimer’s & Other Favorite February Reads
• 

  Lauren Miller and Seth Rogen Fight Alzheimer’s With Comedy
• 

  Studies Show ApoE4 Carriers Appear More Susceptible to COVID-19—Experts Say the Jury Is Still Out

Previous232425Next